Cano Health, Inc.
CANO · NYSE
9/30/2023 | 6/30/2023 | 3/31/2023 | 12/31/2022 | |
|---|---|---|---|---|
| Revenue | $788 | $767 | $867 | $680 |
| % Growth | 2.8% | -11.6% | 27.4% | – |
| Cost of Goods Sold | $772 | $826 | $777 | $573 |
| Gross Profit | $16 | -$60 | $90 | $107 |
| % Margin | 2% | -7.8% | 10.4% | 15.7% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $96 | $97 |
| SG&A Expenses | $81 | $99 | $96 | $108 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $11 |
| Other Operating Expenses | -$1 | $1 | $27 | $26 |
| Operating Expenses | $108 | $189 | $124 | $134 |
| Operating Income | -$467 | -$246 | -$34 | -$26 |
| % Margin | -59.2% | -32% | -3.9% | -3.9% |
| Other Income/Exp. Net | -$25 | -$27 | -$27 | -$405 |
| Pre-Tax Income | -$492 | -$273 | -$61 | -$300 |
| Tax Expense | -$0 | -$2 | -$32 | $2 |
| Net Income | -$260 | -$141 | -$28 | -$302 |
| % Margin | -33.1% | -18.4% | -3.2% | -44.3% |
| EPS | -49.35 | -26.67 | -5.59 | -61.7 |
| % Growth | -85% | -377.1% | 90.9% | – |
| EPS Diluted | -49.35 | -26.67 | -5.59 | -61.7 |
| Weighted Avg Shares Out | 5 | 5 | 5 | 5 |
| Weighted Avg Shares Out Dil | 5 | 5 | 5 | 5 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $30 | $27 | $24 | $20 |
| Depreciation & Amortization | $27 | $27 | $28 | $26 |
| EBITDA | -$435 | -$220 | -$9 | -$1 |
| % Margin | -55.3% | -28.6% | -1.1% | -0.1% |